SOLV
Solventum Corporation
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Best Medical Devices Stocks 2026 →
Solventum (SOLV) Stock: Buy, Sell, or Hold?
$88.62
-1.46 (-1.62%)
▼
5d:
-0.82%
30d:
+2.69%
90d:
+2.5%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 05, 2026
0d
Protect SOLV Gains
Updated Nov 11, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (27%)
Quality Score
35/100
Position
EXTENDED
30-Day Fair Range
$84.30 – $88.55
Position: EXTENDED
Forward P/E & Valuation
11.9x
FAIR
vs 11.4x historical avg
Wall Street Target
$97.69
+10.2% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$80.76 / $93.10
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: SOLV shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When SOLV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$101.85
Based on 3.7% avg growth
INTRINSIC VALUE TODAY
$63.24
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SOLV is currently trading at $88.62, which is considered extended relative to its 30-day fair value range of $84.30 to $88.55. The stock's valuation (Forward PE: 11.9) is in line with its historical norms (11.4). At these levels, the market is pricing in 1.3% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, SOLV is in a uptrend. Immediate support is located at $80.76, while resistance sits at $93.10.
Market Sentiment: SOLV scores 18/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $97.69 (+10.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SOLV is in a uptrend. Immediate support is located at $80.76, while resistance sits at $93.10.
Market Sentiment: SOLV scores 18/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $97.69 (+10.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$84.30 -
$88.55
Company Quality Score
35/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
27.1%
Trading Range & Key Levels
30-Day Trading Range
$84.30 -
$88.55
Current vs Trading Range
EXTENDED
Support Level
$80.76
Resistance Level
$93.10
Current Trend
Uptrend
Technical data as of
Nov 11, 2026
Protect Your Profits
Holding SOLV? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (18/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($97.69)
- NEUTRAL: Market pricing in 1.3% annual earnings growth - fairly valued
- WARNING: Composite score 35/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
11.87
Wall Street Target
$97.69
(+10.2%)
Revenue Growth (YoY)
-7.0%
Earnings Growth (YoY)
3.9%
Profit Margin
1.9%
Valuation Premium vs History
+1.3% premium
PE vs Historical
11.9 vs 11.4
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.3%
(market-implied from PE analysis)
1-Year Target
$89.77
(+1%)
2-Year Target
$90.94
(+3%)
3-Year Target
$92.12
(+4%)
3-Yr Target (if PE normalizes)
(PE: 12→11)
PE COMPRESSION
$88.50
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 3.3%)
$163.40
(+84%)
Base:
(SPY PE: 11.9, Growth: 3.3%)
$97.63
(+10%)
Bear:
(PE: 10.1, Growth: 3.3%)
$82.99
(-6%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (13x PE), but valuation improves significantly next year (12x PE) as earnings recover.
Forward PE: 13.09 | Forward EPS (Implied): $6.77
Bull Case
$107.01
(+21%)
Analyst growth 15.0%, PE expands to 13.7
Base Case
$88.62
(0%)
Market implied 0.0%, PE stable at 13.1
Bear Case
$67.79
(-24%)
Severe decline -15.0%, PE contracts to 11.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share SOLV Analysis
Share this live SOLV analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (SOLV)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Aug 13, 2026
Daily AI digest
AI Retail Discussion Summary:
The Q1 earnings season for the surgical equipment & consumables industry, including Solventum (SOLV), showed satisfactory results with a revenue beat of 1.1%. Solventum reported a strong Q1 with revenues of $2.01 billion, down 3% YoY but exceeding analysts' expectations by 1.9%.
Key Retail Themes:
Solventum's strong Q1 earnings results
Industry trends and growth opportunities
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 2:45 AM ET
Data refreshes hourly during market hours. Next update: 3:45 AM
Data refreshes hourly during market hours. Next update: 3:45 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SOLV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
STRONG BUY
34 analysts |
$486 | 40 SELL |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$82 | 44 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
21 analysts |
$203 | 49 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
16 analysts |
$471 | 50 HOLD |
|
RMD
ResMed Inc |
HOLD
20 analysts |
$264 | 58 HOLD |
Advanced SOLV Option Strategies
Professional options setups generated by AI based on today's SOLV price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive SOLV Research Pages
